Debt-to-equity of Panbela Therapeutics, Inc. from 30 Sep 2013 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Panbela Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2013 to 30 Sep 2024.
  • Panbela Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2024 was -201%, a 88% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Panbela Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2024 -201% +1512% +88% 30 Sep 2024
Q2 2024 -302% +308% +50% 30 Jun 2024
Q1 2024 -1040% -764% -276% 31 Mar 2024
Q4 2023 42564% 31 Dec 2023
Q3 2023 -1712% 30 Sep 2023
Q2 2023 -610% 30 Jun 2023
Q1 2023 -276% 31 Mar 2023
Q2 2015 -106% -460% -130% 30 Jun 2015
Q1 2015 -115% -394% -141% 31 Mar 2015
Q4 2014 -119% -357% -150% 31 Dec 2014
Q3 2014 530% +1291% 30 Sep 2014
Q2 2014 354% 30 Jun 2014
Q1 2014 279% 31 Mar 2014
Q4 2013 238% 31 Dec 2013
Q3 2013 -761% 30 Sep 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.